Pykus Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Mifflin Pl Ste 320, Cambridge, Massach...Phone Number
(617) 394-8960Website
www.pykustherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Pykus Therapeutics
Pykus Therapeutics is dedicated to enhancing the patient experience and outcomes following retinal surgery through its innovative product, PYK-2101. This biodegradable retinal sealant allows for recovery without the need for facedown positioning or blurred vision, significantly improving surgical and visual outcomes. Founded in 2016, the company aims to address the burdens faced by patients undergoing vitrectomies, with over 1.8 million such surgeries performed annually. PYK-2101 is currently an investigational device and has not yet received FDA approval.Explore more
Pykus Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pykus Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Pykus Therapeutics launches new products
Funding: Get notified immidiatlly once Pykus Therapeutics has new funding data
Earning: See what the market has to say on Pykus Therapeutics recently announced quarterly report
Check if Pykus Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Pykus Therapeutics had a recent Job posting/layoffs
Check out if Pykus Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Pykus Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Pykus Therapeutics
Recommended Actions
Find VP level buyers at Pykus Therapeutics
Find more new buyers
Compare Similar Companies to Pykus Therapeutics
Compare insights from companies similar to Pykus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pykus Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pykus Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pykus Therapeutics.
Pykus Therapeutics Tech Stack
A closer look at the technologies used by Pykus Therapeutics
Pykus Therapeutics News & Media
Pykus Therapeutics Completes Trial Enrollment for PYK-2101, a Novel Retinal Sealant for the Treatment for Retinal Detachment
-- PYK-2101 eliminates 'face down positioning' after retinal surgery and is designed to improve visual and anatomical outcomes -- -- Pykus to Provide Interim Study Results in Q2 2025 -- CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc. ("Pykus" or the "Company")...Pykus Therapeutics Selected to Present at the Euretina Special Focus Meeting on Ocular Endotamponades in Athens, Greece
-- Pykus to provide an update of its ongoing Clinical Pilot Study evaluating PYK-2101, a First-in-Class Retinal Sealant, for the treatment of retinal detachment -- CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a clinical-stage...Pykus Therapeutics Expands Patent Portfolio for PYK-2101, a First-in-class Retinal Sealant Delivery Technology
-- PYK-2101 aims to provide rapid visual recovery, enhanced outcomes, and a dramatically improved post-operative experience for patients with retinal detachment, addressing critical unmet needs-- CAMBRIDGE, Mass., Feb. 26, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc. ("Pykus" or the...Pykus Therapeutics to Present Initial Clinical Data on PYK-2101, a Novel Retinal Sealant, at the Vail Vitrectomy 2025 Meeting
--PYK-2101 Aims to Provide Dramatic Improvement in Patient Outcomes and Post-operative Experience Following Retinal Detachment Procedures-- CAMBRIDGE, Mass., Feb. 6, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc., a clinical-stage medical technology company developing a novel retinal...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pykus Therapeutics
Sign Up For FreeTo access detailed company insights
Pykus Therapeutics is dedicated to enhancing the patient experience and outcomes following retinal surgery through its innovative product, PYK-2101. This biodegradable retinal sealant allows for recovery without the need for facedown positioning or blurred vision, significantly improving surgical and visual outcomes. Founded in 2016, the company ai... Read More
